Literature DB >> 27088295

Brief Report: Cumulative Tenofovir Disoproxil Fumarate Exposure is Associated With Biomarkers of Tubular Injury and Fibrosis in HIV-Infected Men.

Vasantha Jotwani1, Rebecca Scherzer, Michelle M Estrella, Lisa P Jacobson, Mallory D Witt, Frank Palella, Bernard Macatangay, Michael Bennett, Chirag R Parikh, Joachim H Ix, Michael Shlipak.   

Abstract

Tenofovir disoproxil fumarate (TDF) can cause kidney damage, but current clinical tests are insensitive for detecting toxicity. Among 884 HIV-infected men enrolled in the Multicenter AIDS Cohort Study, we measured urine biomarkers specific for tubular damage (interleukin-18, kidney injury molecule-1, procollagen type III N-terminal propeptide) and albuminuria. In adjusted analyses, each year of TDF exposure was independently associated with 3.3% higher interleukin-18 (95% CI: 0.8% to 5.8%), 3.4% higher kidney injury molecule-1 (1.1% to 5.7%), and 3.1% higher procollagen type III N-terminal propeptide (0.8% to 5.5%), but not with albuminuria (2.8%; -0.6% to 6.2%). Biomarkers of tubular damage may be more sensitive than albuminuria for detecting toxicity from TDF and other medications.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27088295      PMCID: PMC5023456          DOI: 10.1097/QAI.0000000000001027

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  48 in total

1.  Impairment in kidney tubular function in patients receiving tenofovir is associated with higher tenofovir plasma concentrations.

Authors:  Sonia Rodríguez-Nóvoa; Pablo Labarga; Antonio D'avolio; Pablo Barreiro; Marta Albalate; Eugenia Vispo; Carmen Solera; Marco Siccardi; Stefano Bonora; Giovanni Di Perri; Vincent Soriano
Journal:  AIDS       Date:  2010-04-24       Impact factor: 4.177

2.  Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury.

Authors:  T Ichimura; J V Bonventre; V Bailly; H Wei; C A Hession; R L Cate; M Sanicola
Journal:  J Biol Chem       Date:  1998-02-13       Impact factor: 5.157

Review 3.  Clinical evaluation of kidney function--glomerular function.

Authors:  J P Kassirer
Journal:  N Engl J Med       Date:  1971-08-12       Impact factor: 91.245

4.  Urinary procollagen III aminoterminal propeptide (PIIINP): a fibrotest for the nephrologist.

Authors:  Balsam El Ghoul; Tarek Squalli; Aude Servais; Caroline Elie; Vannary Meas-Yedid; Christine Trivint; Jill Vanmassenhove; Jean-Pierre Grünfeld; Jean-Christophe Olivo-Marin; Eric Thervet; Laure-Hélène Noël; Dominique Prié; Fadi Fakhouri
Journal:  Clin J Am Soc Nephrol       Date:  2010-01-14       Impact factor: 8.237

5.  Subclinical tubular injury in HIV-infected individuals on antiretroviral therapy: a cross-sectional analysis.

Authors:  Andrew M Hall; Simon G Edwards; Marta Lapsley; John O Connolly; Kreesan Chetty; Stephen O'Farrell; Robert J Unwin; Ian G Williams
Journal:  Am J Kidney Dis       Date:  2009-09-23       Impact factor: 8.860

6.  The effect of lopinavir/ritonavir on the renal clearance of tenofovir in HIV-infected patients.

Authors:  J J Kiser; M L Carten; C L Aquilante; P L Anderson; P Wolfe; T M King; T Delahunty; L R Bushman; C V Fletcher
Journal:  Clin Pharmacol Ther       Date:  2007-06-27       Impact factor: 6.875

7.  Greater tenofovir-associated renal function decline with protease inhibitor-based versus nonnucleoside reverse-transcriptase inhibitor-based therapy.

Authors:  Miguel Goicoechea; Shanshan Liu; Brookie Best; Shelly Sun; Sonia Jain; Carol Kemper; Mallory Witt; Catherine Diamond; Richard Haubrich; Stan Louie
Journal:  J Infect Dis       Date:  2008-01-01       Impact factor: 5.226

8.  Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury.

Authors:  Won K Han; Veronique Bailly; Rekha Abichandani; Ravi Thadhani; Joseph V Bonventre
Journal:  Kidney Int       Date:  2002-07       Impact factor: 10.612

9.  Urinary interleukin-18 is a marker of human acute tubular necrosis.

Authors:  Chirag R Parikh; Alkesh Jani; Vyacheslav Y Melnikov; Sarah Faubel; Charles L Edelstein
Journal:  Am J Kidney Dis       Date:  2004-03       Impact factor: 8.860

10.  Fanconi syndrome accompanied by renal function decline with tenofovir disoproxil fumarate: a prospective, case-control study of predictors and resolution in HIV-infected patients.

Authors:  Samir K Gupta; Albert M Anderson; Ramin Ebrahimi; Todd Fralich; Hiba Graham; Valeska Scharen-Guivel; John F Flaherty; Claude Fortin; Robert C Kalayjian; Anita Rachlis; Christina M Wyatt
Journal:  PLoS One       Date:  2014-03-20       Impact factor: 3.240

View more
  8 in total

Review 1.  Potential kidney toxicity from the antiviral drug tenofovir: new indications, new formulations, and a new prodrug.

Authors:  Lili Chan; Benjamin Asriel; Ellen F Eaton; Christina M Wyatt
Journal:  Curr Opin Nephrol Hypertens       Date:  2018-03       Impact factor: 2.894

2.  Pre-exposure Prophylaxis With Tenofovir Disoproxil Fumarate/Emtricitabine and Kidney Tubular Dysfunction in HIV-Uninfected Individuals.

Authors:  Vasantha Jotwani; Rebecca Scherzer; David V Glidden; Megha Mehrotra; Patricia Defechereux; Albert Liu; Monica Gandhi; Michael Bennett; Steven G Coca; Chirag R Parikh; Robert M Grant; Michael G Shlipak
Journal:  J Acquir Immune Defic Syndr       Date:  2018-06-01       Impact factor: 3.731

Review 3.  Kidney Disease in HIV: Moving beyond HIV-Associated Nephropathy.

Authors:  Vasantha Jotwani; Mohamed G Atta; Michelle M Estrella
Journal:  J Am Soc Nephrol       Date:  2017-08-07       Impact factor: 10.121

4.  Association of HIV infection with biomarkers of kidney injury and fibrosis in the Multicenter AIDS Cohort Study.

Authors:  Vasantha Jotwani; Rebecca Scherzer; Michelle M Estrella; Lisa P Jacobson; Mallory D Witt; Frank Palella; Ken Ho; Michael Bennett; Chirag R Parikh; Joachim H Ix; Michael Shlipak
Journal:  Antivir Ther       Date:  2017-01-05

5.  Tenofovir disoproxil fumarate initiation and changes in urinary biomarker concentrations among HIV-infected men and women.

Authors:  William R Zhang; Rebecca Scherzer; Michelle M Estrella; Simon B Ascher; Anthony Muiru; Vasantha Jotwani; Carl Grunfeld; Chirag R Parikh; Deborah Gustafson; Seble Kassaye; Anjali Sharma; Mardge Cohen; Phyllis C Tien; Derek K Ng; Frank J Palella; Mallory D Witt; Ken Ho; Michael G Shlipak
Journal:  AIDS       Date:  2019-03-15       Impact factor: 4.177

Review 6.  Urinary Markers of Tubular Injury in HIV-Infected Patients.

Authors:  Temesgen Fiseha; Angesom Gebreweld
Journal:  Biochem Res Int       Date:  2016-07-17

7.  Long Term Exposure to Tenofovir Disoproxil Fumarate-Containing Antiretroviral Therapy Is Associated with Renal Impairment in an African Cohort of HIV-Infected Adults.

Authors:  Oche O Agbaji; Isaac O Abah; Augustine O Ebonyi; Zumnan M Gimba; Esla E Abene; Simji S Gomerep; Kakjing D Falang; Joseph Anejo-Okopi; Patricia A Agaba; Placid O Ugoagwu; Emmanuel I Agaba; Godwin E Imade; Atiene S Sagay; Prosper Okonkwo; John A Idoko; Phyllis J Kanki
Journal:  J Int Assoc Provid AIDS Care       Date:  2019 Jan-Dec

8.  Shorter Time to Discontinuation Due to Treatment Failure in People Living with HIV Switched to Dolutegravir Plus Either Rilpivirine or Lamivudine Compared with Integrase Inhibitor-Based Triple Therapy in a Large Spanish Cohort.

Authors:  Ramón Teira; Helena Diaz-Cuervo; Filipa Aragão; Manuel Castaño; Alberto Romero; Bernardino Roca; Marta Montero; Maria José Galindo; Maria Jose Muñoz-Sánchez; Nuria Espinosa; Joaquim Peraire; Elisa Martínez; Belén de la Fuente; Pere Domingo; Elisabeth Deig; María Dolores Merino; Paloma Geijo; Vicente Estrada; María Antonia Sepúlveda; Josefina García; Juan Berenguer; Adriá Currán
Journal:  Infect Dis Ther       Date:  2022-04-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.